Perturbation response scanning of drug-target networks: Drug repurposing for multiple sclerosis
Open Access
- 9 April 2025
- journal article
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 15 (6) , 101295
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20220494)
- Second Affiliated Hospital of Soochow University (ND2022A04)
- State Key Laboratory of Drug Research, Chinese Academy of Sciences (SKLDR-2023-KF-05)
- National Natural Science Foundation of China (32271292, 32200778, 22377089, 31872723)
- Science and Technology Program of Suzhou
- Priority Academic Program Development of Jiangsu Higher Education Institutions
This publication has 50 references indexed in Scilit:
- NetSDR: Drug repurposing for cancers based on subtype-specific network modularization and perturbation analysisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2025
- Antinociceptive effects of nefopam activating descending serotonergic modulation via 5‐HT2 receptors in the nucleus raphe magnusEuropean journal of pain, 2023
- Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer’s diseaseCell Reports, 2022
- Systems analysis of de novo mutations in congenital heart diseases identified a protein network in the hypoplastic left heart syndromeCell Systems, 2022
- Drug Repurposing: A Network-based Approach to Amyotrophic Lateral SclerosisNeurotherapeutics, 2021
- Polyphenols in the treatment of autoimmune diseasesAutoimmunity Reviews, 2019
- Evolutionary considerations on 5-HT2 receptorsPharmacological Research, 2019
- Walking the Interactome for Prioritization of Candidate Disease GenesThe American Journal of Human Genetics, 2008
- Anisotropy of Fluctuation Dynamics of Proteins with an Elastic Network ModelBiophysical Journal, 2001
- Direct evaluation of thermal fluctuations in proteins using a single-parameter harmonic potentialFolding and Design, 1997